Reduced Taurine Transporter Expression in Lymphoblastoid Cell Lines From Alzheimer's Disease Patients Compared With Age‐Matched Controls: Therapeutic Implications?

Documenti analoghi

• Enriching iPSC research diversity: Harnessing human biobank collections for improved ethnic representation
  di: David Gurwitz, et al.
  Pubblicazione: (2024)
• Management of Alzheimer's Disease With Nanotechnological Interventions and Novel Therapeutics
  di: Mohd Shahrukh, et al.
  Pubblicazione: (2025)
• All Lines Is the Right Approach: Selecting Patient Lines of Therapy for an External Comparator Arm
  di: Daniel Backenroth, et al.
  Pubblicazione: (2025)
• Rational Discovery of BACE1‐Selective Inhibitors as Potential Therapeutics for Alzheimer's Disease
  di: Tanmaykumar Varma, et al.
  Pubblicazione: (2025)
• Pharmacophore‐Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases
  di: Chung‐Ting Kuo, et al.
  Pubblicazione: (2026)